SCHEMBL24578202

SCHEMBL24578202

CC(=O)c1cnn2cc(-c3cn[nH]c3)sc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC7 O00311 4/20 0.35
▸ DBF4 Q9UBU7 4/20 0.35
▸ CCNE1 P24864 3/20 0.35
▸ CDK2 P24941 3/20 0.35
▸ ROCK1 Q13464 3/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ GPR35 Q9HC97 1/20 0.34
▸ ROCK2 O75116 4/20 0.33
▸ BMPR1B O00238 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ BMPR1A P36894 1/20 0.33
▸ ACVRL1 P37023 1/20 0.33
▸ TGFBR2 P37173 1/20 0.33
▸ ACVR1 Q04771 1/20 0.33
▸ BMPR2 Q13873 1/20 0.33
▸ PRKAB1 Q9Y478 1/20 0.33
▸ CHEK1 O14757 2/20 0.32
▸ CHEK2 O96017 2/20 0.32
▸ ABL1 P00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24576965 0.86 CHEK1 (0.37) CDC7DBF4CCNE1CDK2ROCK1
Hydrochloric Acid SCHEMBL29759885 0.85 CHEK1 (0.37) CDC7DBF4CCNE1CDK2ROCK1
SCHEMBL24576968 0.80 BRD4 (0.41) PTGS1PTGS2CHEK1MARK3
SCHEMBL24578249 0.77 KDM4E (0.43) ABL1
SCHEMBL24577782 0.75 PTGS1 (0.33) PTGS1PTGS2
SCHEMBL24577992 0.74 IKBKE (0.42) CDK2ROCK1TGFBR2ABL1
SCHEMBL17454470 0.74 HAT1 (0.48) ROCK1ROCK2BMPR1BKDRBMPR1A
SCHEMBL24578329 0.73 MAPT (0.30) MAPTHPGD
SCHEMBL24577563 0.73 KIT (0.40) PTGS1PTGS2KDRABL1
SCHEMBL24578161 0.72 RAB9A (0.36) MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback